 |
|
National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS)
AREDS Report No. 10
Traci E. Clemons, PhD;
Emily Y. Chew, MD;
Susan B. Bressler, MD;
Wendy McBee, MA;
for the AREDS Research Group
Arch Ophthalmol. 2003;121:211-217.
Objectives To describe the vision-targeted, health-related quality of life, measured with the National Eye Institute Visual Function Questionnaire (NEI-VFQ), in patients with age-related macular degeneration, cataract, or reduced visual acuity; to determine the relationship between the NEI-VFQ subscale scores and clinical measures of visual function; and to assess the internal consistency and reliability of the NEI-VFQ subscales.
Design The 39-item NEI-VFQ was administered at the 5-year clinic visit to 4077 Age-Related Eye Disease Study participants.
Results The subscales of the NEI-VFQ had moderate to high internal consistency (Cronbach's  = 0.58-0.91). The NEI-VFQ scores for participants with advanced age-related macular degeneration in 1 or both eyes, severe nuclear opacity, reduced visual acuity, or cataract surgery generally were lower than scores for disease-free participants (P<.001).
Conclusion These findings support the use of the NEI-VFQ as a measure of vision-targeted, health-related quality of life among patients with age-related macular degeneration, cataract, or reduced visual acuity.
From the AREDS Research Group. A complete list of the members of the AREDS Research Group was published previously (Arch Ophthalmol. 2001;119:1439-1452). Authors have no relevant financial interest in this article.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Evaluation of Quality of Life and Priorities of Patients with Glaucoma
Aspinall et al.
IOVS 2008;49:1907-1915.
ABSTRACT
| FULL TEXT
Impact of Glaucoma, Lens Opacities, and Cataract Surgery on Visual Functioning and Related Quality of Life: The Barbados Eye Studies
Wu et al.
IOVS 2008;49:1333-1338.
ABSTRACT
| FULL TEXT
Improved Vision-Related Function After Ranibizumab Treatment of Neovascular Age-Related Macular Degeneration: Results of a Randomized Clinical Trial
Chang et al.
Arch Ophthalmol 2007;125:1460-1469.
ABSTRACT
| FULL TEXT
Eye Care in the United States: Do We Deliver to High-Risk People Who Can Benefit Most From It?
Zhang et al.
Arch Ophthalmol 2007;125:411-418.
ABSTRACT
| FULL TEXT
Quality of Life After Iodine 125 Brachytherapy vs Enucleation for Choroidal Melanoma: 5-Year Results From the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
Collaborative Ocular Melanoma Study-Quality of Lif
Arch Ophthalmol 2006;124:226-238.
ABSTRACT
| FULL TEXT
Responsiveness of the National Eye Institute Visual Function Questionnaire to Progression to Advanced Age-Related Macular Degeneration, Vision Loss, and Lens Opacity: AREDS Report No. 14
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2005;123:1207-1214.
ABSTRACT
| FULL TEXT
The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of the Protein Kinase C {beta} Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial
The PKC-DRS Study Group
Diabetes 2005;54:2188-2197.
ABSTRACT
| FULL TEXT
Age-Related Eye Disease, Quality of Life, and Functional Activity
Knudtson et al.
Arch Ophthalmol 2005;123:807-814.
ABSTRACT
| FULL TEXT
Health- and Vision-Related Quality of Life Among Patients With Ocular Histoplasmosis or Idiopathic Choroidal Neovascularization at Enrollment in a Randomized Trial of Submacular Surgery: Submacular Surgery Trials Report No. 5
Submacular Surgery Trials Research Group
Arch Ophthalmol 2005;123:78-88.
ABSTRACT
| FULL TEXT
|
